The Clostridium vaccine market is estimated to be valued at US$ 2.3 Bn in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Clostridium vaccine is used for protection against Clostridium species infection in livestock animals including cattle, sheep, and others. Clostridium bacteria can cause dangerous diseases in livestock such as blackleg, malignant edema, enterotoxemia, and black disease. Clostridium vaccine provides immunity against these fatal diseases thus supporting healthy livestock.
Market Dynamics:
Growing prevalence of clostridial diseases in livestock is expected to drive the clostridium vaccine market growth. For instance, according to Agriculture and Horticulture Development Board, 2018, clostridial diseases including blackleg, tetanus, and pulpy kidney account for significant livestock mortality and economic losses in UK. Moreover, rising awareness among livestock owners regarding economic benefits of clostridium vaccination is also anticipated to support the market growth during the forecast period. However, higher costs associated with veterinary vaccination compared to oral drugs and fluctuations in raw material prices may hinder the market growth.
SWOT Analysis
Strength: Clostridium Vaccine Market has gained popularity due to rising pet adoption rate across the globe. Increasing awareness levels regarding veterinary vaccinations among pet owners is further driving the demand. Stringent regulatory guidelines for animal vaccination also boost the market growth.
Weakness: High costs involved in research & development activities for Clostridium vaccines can restrain the market growth. Stringent regulatory approvals and time-consuming clinical trials also hamper the Clostridium Vaccine Market growth.
Opportunity: Growing animal healthcare spending in emerging economies like India and China offer lucrative opportunities. Technological advancements in vaccine development methods open new avenues.
Threats: Alternatives like antibiotics pose threat to Clostridium Vaccines Market. Threat from cheap generic brands further intensifies the competition.
Key Takeaways
The Global Clostridium Vaccine Market Size is expected to witness high growth, exhibiting a CAGR of 4.2% over the forecast period, due to increasing pet adoption worldwide. Rapid urbanization and rising disposable incomes have significantly boosted pet owning culture globally.
Regional analysis: North America dominates the Clostridium Vaccine Market currently owing to robust veterinary infrastructure and heightened awareness regarding animal health. Asia Pacific is anticipated to register fastest growth rate owing to growing pet care industry and increasing spending on animal health.
Key players analysis: Key players operating in the Clostridium Vaccine market are Merck Animal Health, Zoetis Inc., Boehringer Ingelheim GmbH, Elanco Animal Health, Ceva Santé Animale, Virbac SA, Bayer AG, Intervet Inc., Bimeda, Ouroboros Biologicals, Novartis Animal Health, Hygieia Biological Laboratories, Valneva SE, Vetoquinol. These companies are primarily focusing on expanding their product portfolios through strategic collaborations and new product launches.
For More Insights
https://www.trendingwebwire.com/clostridium-vaccine-market-share-size-forecast-outlook-2023-2030/
